News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,414 Results
Type
Article (40622)
Company Profile (286)
Press Release (654506)
Section
Business (206393)
Career Advice (2112)
Deals (35802)
Drug Delivery (96)
Drug Development (81412)
Employer Resources (171)
FDA (16176)
Job Trends (14906)
News (348383)
Policy (32873)
Tag
Academia (2567)
Alliances (49535)
Alzheimer's disease (1269)
Approvals (16124)
Artificial intelligence (145)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (201)
Breast cancer (189)
Cancer (1371)
Cardiovascular disease (110)
Career advice (1765)
Cell therapy (285)
Clinical research (65078)
Collaboration (487)
Compensation (260)
COVID-19 (2578)
C-suite (112)
Data (1389)
Diabetes (173)
Diagnostics (6207)
Earnings (85962)
Employer resources (149)
Events (111016)
Executive appointments (403)
FDA (16847)
Funding (431)
Gene therapy (198)
GLP-1 (611)
Government (4428)
Healthcare (18876)
Infectious disease (2671)
Inflammatory bowel disease (112)
Interviews (330)
IPO (16480)
Job creations (3669)
Job search strategy (1504)
Layoffs (422)
Legal (7984)
Lung cancer (198)
Lymphoma (98)
Manufacturing (218)
Medical device (13300)
Medtech (13305)
Mergers & acquisitions (19478)
Metabolic disorders (459)
Neuroscience (1597)
NextGen Class of 2024 (6560)
Non-profit (4506)
Northern California (1700)
Obesity (263)
Opinion (190)
Patents (118)
People (57376)
Phase I (20243)
Phase II (28658)
Phase III (21374)
Pipeline (517)
Postmarket research (2603)
Preclinical (8604)
Radiopharmaceuticals (243)
Rare diseases (261)
Real estate (5948)
Regulatory (21886)
Research institute (2340)
Resumes & cover letters (361)
Southern California (1466)
Startups (3610)
United States (15227)
Vaccines (576)
Weight loss (186)
Date
Last 7 days (588)
Last 30 days (2269)
Last 365 days (35410)
2024 (35249)
2023 (40357)
2022 (51465)
2021 (55991)
2020 (54432)
2019 (46949)
2018 (35378)
2017 (32490)
2016 (31930)
2015 (37949)
2014 (31729)
2013 (26767)
2012 (29001)
2011 (29673)
2010 (27734)
Location
Africa (745)
Arizona (197)
Asia (38072)
Australia (6245)
California (3825)
Canada (1450)
China (308)
Colorado (174)
Connecticut (179)
Europe (81794)
Florida (534)
Georgia (136)
Illinois (388)
Indiana (224)
Maryland (627)
Massachusetts (2975)
Michigan (172)
Minnesota (291)
New Jersey (1113)
New York (1084)
North Carolina (761)
Northern California (1700)
Ohio (148)
Pennsylvania (924)
South America (1119)
Southern California (1466)
Texas (547)
Utah (110)
Washington State (399)
695,414 Results for "petvivo holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
PetVivo Reports Reports Fiscal 2024 Results
PetVivo Holdings, Inc., a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024.
June 28, 2024
·
10 min read
BioMidwest
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
PetVivo Holdings, Inc. announced that the Company has released the results of a clinical study conducted by Inotiv, Inc., a world-renowned independent clinical research organization, which examined the safety of intra-articular injections of collagen-elastin hydrogel microparticulates into the joints of cats.
February 7, 2024
·
4 min read
Business
PetVivo Reports Second Quarter of Fiscal 2024 Financial Results
PetVivo Holdings, Inc. announces financial results for the three months ended September 30, 2023.
November 14, 2023
·
10 min read
BioMidwest
PetVivo Recieves Notice of Allowance from United States Patent and Trademark Office for Key Patent Application
PetVivo Holdings, Inc. an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals is pleased to announce that the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company’s proprietary biocompatible protein-based particles.
August 17, 2023
·
3 min read
Press Releases
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
December 20, 2024
·
2 min read
Press Releases
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
December 18, 2024
·
4 min read
Press Releases
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
December 10, 2024
·
10 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Business
PetVivo Reports Third Quarter of Fiscal 2023 Financial Results
PetVivo Holdings, Inc., an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the third quarter of fiscal 2023.
February 9, 2023
·
12 min read
Business
Petvivo Holdings, Inc. To Announce Results for the Year 2022 Ended March 31, 2022
PetVivo Holdings, Inc., an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals, will report financial results for the year ending March 31, 2022, on Wednesday, June 29, 2022 after market close.
June 21, 2022
·
2 min read
1 of 69,542
Next
